Acenocoumarol
Allopurinol may increase the anticoagulant activities of Acenocoumarol.
Aluminum
Aluminium can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Allopurinol.
Advertisement
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Allopurinol.
Aminophylline
The serum concentration of Aminophylline can be increased when it is combined with Allopurinol.
Amoxicillin
The risk of a hypersensitivity reaction to Amoxicillin is increased when it is combined with Allopurinol.
Advertisement
Amoxicillin Anhydrous
The risk of a hypersensitivity reaction to Amoxicillin is increased when it is combined with Allopurinol.
Ampicillin
The risk of a hypersensitivity reaction to Ampicillin is increased when it is combined with Allopurinol.
Ampicillin (anhydrous)
The risk of a hypersensitivity reaction to Ampicillin is increased when it is combined with Allopurinol.
Azathioprine
The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.
Azosemide
The risk or severity of adverse effects can be increased when Azosemide is combined with Allopurinol.
Benazepril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Benazepril.
Bendamustine
The risk or severity of adverse effects can be increased when Allopurinol is combined with Bendamustine.
Bendroflumethiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Bendroflumethiazide.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bumetanide
The risk or severity of adverse effects can be increased when Bumetanide is combined with Allopurinol.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Captopril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Captopril.
Carbamazepine
The serum concentration of Carbamazepine can be increased when it is combined with Allopurinol.
Chlorothiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Chlorothiazide.
Chlorpropamide
The serum concentration of Chlorpropamide can be increased when it is combined with Allopurinol.
Chlorthalidone
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Chlorthalidone.
Cilazapril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Cilazapril.
Cyclopenthiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Cyclopenthiazide.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Allopurinol is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Allopurinol is combined with Cyclophosphamide.
Dicumarol
Allopurinol may increase the anticoagulant activities of Dicoumarol.
Didanosine
The serum concentration of Didanosine can be increased when it is combined with Allopurinol.
Dyphylline
The serum concentration of Dyphylline can be increased when it is combined with Allopurinol.
Enalapril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Enalapril.
Enalaprilat
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Enalaprilat.
Ethacrynate
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Allopurinol.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Allopurinol.
Fluindione
Allopurinol may increase the anticoagulant activities of Fluindione.
Fosinopril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Fosinopril.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Allopurinol.
Hydrochlorothiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydrochlorothiazide.
Hydroflumethiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydroflumethiazide.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Imidapril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Imidapril.
Indapamide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Indapamide.
Lisinopril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Lisinopril.
Lisinopril Anhydrous
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Lisinopril.
Magaldrate
Magaldrate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mercaptopurine
The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.
MERCAPTOPURINE ANHYDROUS
The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.
Methyclothiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Methyclothiazide.
Metolazone
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Metolazone.
Moexipril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Moexipril.
Pegloticase
The risk or severity of adverse effects can be increased when Allopurinol is combined with Pegloticase.
Perindopril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Perindopril.
Phenindione
Allopurinol may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Allopurinol may increase the anticoagulant activities of Phenprocoumon.
Piretanide
The risk or severity of adverse effects can be increased when Piretanide is combined with Allopurinol.
Polythiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Polythiazide.
Quinapril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinapril.
Quinethazone
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinethazone.
Ramipril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Ramipril.
Rescinnamine
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Rescinnamine.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Allopurinol.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Spirapril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Spirapril.
Tegafur
The therapeutic efficacy of Tegafur can be decreased when used in combination with Allopurinol.
Theophylline
The serum concentration of Theophylline can be increased when it is combined with Allopurinol.
Theophylline anhydrous
The serum concentration of Theophylline can be increased when it is combined with Allopurinol.
Torsemide
The risk or severity of adverse effects can be increased when Torasemide is combined with Allopurinol.
Trandolapril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Trandolapril.
Trichlormethiazide
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Trichlormethiazide.
Tromethamine
Tromethamine can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Warfarin
Allopurinol may increase the anticoagulant activities of Warfarin.
Zofenopril
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Zofenopril.
